|
FAM50A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.174000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.302100E-03 |
| Normal-vs-Stage2 |
1.405610E-02 |
| Normal-vs-Stage3 |
4.359800E-03 |
| Normal-vs-Stage4 |
5.779600E-03 |
| Stage1-vs-Stage2 |
3.927200E-01 |
| Stage1-vs-Stage3 |
4.850400E-01 |
| Stage1-vs-Stage4 |
4.944000E-01 |
| Stage2-vs-Stage3 |
7.501800E-01 |
| Stage2-vs-Stage4 |
8.685600E-01 |
| Stage3-vs-Stage4 |
8.878600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.077870E-02 |
| Normal-vs-AfricanAmerican |
4.743000E-03 |
| Normal-vs-Asian |
8.558200E-03 |
| Caucasian-vs-AfricanAmerican |
2.581800E-01 |
| Caucasian-vs-Asian |
2.894600E-01 |
| AfricanAmerican-vs-Asian |
8.045600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.723000E-03 |
| Normal-vs-Female |
1.440690E-03 |
| Male-vs-Female |
8.365800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.918610E-03 |
| Normal-vs-Age(41-60Yrs) |
7.358000E-03 |
| Normal-vs-Age(61-80Yrs) |
9.622800E-03 |
| Normal-vs-Age(81-100Yrs) |
5.198000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.209200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.591600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.504400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.959400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.236800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.772200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.415600E-01 |
| Classical-VS-Follicular |
1.841890E-03 |
| Classical-VS-Other |
4.537600E-01 |
| Classical-VS-Normal |
4.781500E-02 |
| Tall-VS-Follicular |
1.989390E-01 |
| Tall-VS-Other |
7.735200E-01 |
| Tall-VS-Normal |
5.049600E-02 |
| Follicular-VS-Other |
6.648000E-01 |
| Follicular-VS-Normal |
7.67329999999955E-05 |
| Other-VS-Normal |
1.292630E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.777840E-04 |
| Normal-vs-N1 |
1.283520E-03 |
| N0-vs-N1 |
4.039600E-01 |
|
|
